期刊文献+

结核及肺癌所致胸腔积液中MCP-1、RANTES的表达水平及临床意义 被引量:5

Expression and clinical significance of MCP-1 and RANTES in pleural effusion of patients with tuberculosis or lung cancer
下载PDF
导出
摘要 目的探讨结核以及肺癌所致的胸腔积液中单核细胞超化蛋白-1(MCP-1)和分泌因子(RANTES)的表达水平及临床意义。方法对74例结核性胸腔积液以及64例肺癌致胸腔积液患者进行回顾性分析。对所有患者胸腔积液中MCP-1、RANTES浓度进行检测并进行比较。结果结核组胸腔积液总蛋白、乳酸脱氢酶(LDH)、腺苷酸脱氨酶(ADA)、癌胚抗原(CEA)与肺癌组相比差异均有统计学意义(P﹤0.05);结核组胸腔积液MCP-1浓度、RANTES浓度分别为(2304.9±294.0)pg/ml、(301.5±61.7)pg/ml,均高于肺癌组(P﹤0.05);不同病理类型肺癌患者胸腔积液MCP-1、RANTES浓度比较,差异均无统计学意义(P﹥0.05)。结论 MCP-1、RANTES浓度对于区分结核与肺癌致胸腔积液有着较高的临床价值,但不能区分肺癌的不同病理类型。 Objective To investigate the expression and clinical significance of MCP-1(monocyte chemotactic protein 1) and secreted factors(RANTES) in pleural effusion of patients with tuberculosis or lung cancer. Method 74 cases with tuberculous pleural effusion(tuberculosis group) and 64 cases with lung cancer-induced pleural effusion(lung cancer group) were retrospectively analyzed. Patients' pleural effusion was extracted to detect the expression of MCP-1 and RANTES. Result The expression of total protein, LDH, ADA and CEA in tuberculosis group and lung cancer group was significantly different(P〈0.05); the concentration of MCP-1 and RANTES in tuberculosis group was(2304.9±294.0) pg/ml and(301.5±61.7) pg/ml, and were significantly higher than those in lung cancer group(both P〈0.05); While the concentration of MCP-1 and RANTES in patients with different pathological classifications of lung cancer was of no significant difference(P〈0.05). Conclusion The concentration of MCP-1 and RANTES is of great importance in the clinical differentiation for pleural effusion induced by tuberculosis or lung cancer; Though it may not be applied to distinguish the different pathological classifications of lung cancer.
作者 胡连锋 周文琳 HU Lian-feng ZHOU Wen-lin(Department of Tuberculosis, Qianshan Hospital of Anshan City, Anshan 114001, Liaoning, China)
出处 《癌症进展》 2016年第12期1233-1234,1248,共3页 Oncology Progress
关键词 肺结核 肺癌 胸腔积液 MCP-1 RANTES pulmonary tuberculosis lung cancer pleural effusion MCP-1 RANTES
  • 相关文献

参考文献10

二级参考文献123

  • 1伍建林,李光军,王克礼,李智勇,刘晓峰.多层螺旋CT灌注成像鉴别诊断肺癌与肺良性肿物[J].中国医学影像技术,2005,21(4):551-555. 被引量:69
  • 2Oppenheim .U, Zaehariae CO, Mukaida N, et al. Properties of the novel proinflammatory supergene" intercrine" cytokine family. Annu Rev Immunol, 1991,9:617-648.
  • 3Kamal A. Mohammed. Helper T Cell Type 1 and 2 Cytokines Regulate C-C Chemokine Expression in Mouse Pleural Mesethelial Cells. Am J Respir Crit Care M ed. 1999,159 (5 Pt 1 ) :1653-1659.
  • 4M lotto D, Christod oulopoulos P, Olivensteln R, et al. Expression of IFN-gamma-inducible protein 1 monocyle chemotactlc proteins 1,3, and 4 ;and eotaxin in Thl and Th2 medated lung diseases. Allerg Clin Immunol,2001,107(4) :664-670.
  • 5Hitoshi Katayama, Akihito Yokoyama. Production of Eosinophilic Chemokines by Normal Pleural Mesothelial Cells. Am J Respir Cell Mol Biol,2002,26 (4) :398-403.
  • 6Mohamed I. Sadek. Chemokines Induced by Infection of Mononuclear Phagocytes with Mycobacteria and Present in Lung Alveoli during Active Pulmonary Tuberculosis. Am J Respir Cell Mol Biol, 1998,19(3) :513-521.
  • 7Toulza F,Nosaka K,Tanaka Y,et al.Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+ regulatory T cells.J Immunol,2010,185:183-189.
  • 8Oo YH,Weston CJ,Lalor PF,et al.Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver.J Immunol,2010,184:2886-2898.
  • 9Onodera T,Jang MH,Guo Z,et al.Constitutive expression of IDO by dendritic cells of mesenteric lymph nodes:functional involvement of the CTLA-4/B7 and CCL22/CCR4 interactions.J Immunol,2009,183:5608-5614.
  • 10Gobert M,Treilleux I,Bendriss-Vermare N,et al.Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.Cancer Res,2009,69:2000-2009.

共引文献54

同被引文献51

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部